Agneta Gustafsson joins Intervacc

We have the great pleasure of welcoming Agneta Gustafsson to Intervacc and our initiative – Together against strangles. Agneta, who is a well-established name in the veterinary medicine industry, has renowned specialist competence in equine medicine and she is a...

CEO presentation AGM

This years AGM will be held June 9th 2021 without physical presence of shareholders and shareholder can only can exercise their voting rights by postal voting. A presentation by CEO Andreas Andersson, where he comment upon the Company’s activities during the...

Quality Assurance (QA) Manager at Intervacc

We have an exciting new opportunity for a Quality Assurance (QA) Manager who will be responsible for quality management of external manufacturing and supply of Intervacc’s products. The Quality Manager will have a central role in oversight and management of external...

Global Product Manager for Strangvac

We have an exciting new opportunity for a Global Product Manager for our lead product Strangvac® – a vaccine that promises to be a game changer in the fight against the equine disease Strangles. Strangvac® is expected to be launched commercially in Europe during...

Intervacc to participate at ABGSC Investor Day on September 7

On Monday, September 7, Intervacc’s CEO Andreas Andersson will participate in the live broadcast of ABGSC Investor Day in Stockholm. The company is in an exciting and intensive phase with, among other things, an ongoing process for a European granting of a...